Welcome to our dedicated page for Phreesia SEC filings (Ticker: PHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Phreesia filings document the company’s operating results, material agreements, capital structure and governance as a public healthcare technology company. Recent Form 8-K disclosures include quarterly financial results, stakeholder letters and earnings-call materials, along with material definitive agreements connected to credit facilities, acquisition financing and receivables arrangements.
The filing record also documents the completed AccessOne acquisition, the use and refinancing of related debt, and subsidiary arrangements involving AccessOne Funding and AccessOne MedCard. Governance disclosures include board composition changes, director compensation matters and shareholder-voting subjects, while capital-structure disclosures cover secured revolving credit, bridge-loan obligations and receivables purchase agreements.
Form 144 filing for Phreesia, Inc. (PHR) shows a proposed sale of 3,133 common shares with an aggregate market value of $72,950.03. The shares were acquired on 09/11/2025 through restricted stock vesting and payment classified as compensation. The planned sale date is 09/16/2025 on the NYSE. The filer reported a prior sale within three months: 1,245 shares sold on 07/17/2025 for $33,472.82. The filing lists total outstanding shares as 59,914,473. Several standard identifying fields (issuer address, filer CIK/CCC, and named filer contact) are not provided in the visible content.
Phreesia, Inc. insider filing notifies a proposed sale of 6,328 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $147,343.68, and an approximate sale date of 09/16/2025. The shares were acquired on 09/11/2025 upon restricted stock vesting as compensation. The filer also reported three sales during the past three months totaling 103,164 shares for gross proceeds of $3,210,162.74 (sales on 07/17/2025, 08/27/2025 and 08/28/2025). The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Form 144 filed for Phreesia, Inc. (PHR) reports a proposed sale of 2,051 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $47,756.30 and an approximate sale date of 09/16/2025. The shares were acquired on 09/11/2025 as restricted stock that vested and were received as compensation. The filer certifies no undisclosed material adverse information. The filing also discloses recent open-market sales by insiders in the past three months, including large disposals by David Linetsky totaling 41,174 shares across June–August 2025 and smaller sales by Jessica Weiss.
Form 144 Notice for Phreesia, Inc. (PHR) shows a proposed sale of 114 common shares through Fidelity Brokerage Services on 09/16/2025 with an aggregate market value of $2,654.42. The shares were acquired by the seller on 09/11/2025 upon restricted stock vesting and the consideration is listed as compensation. The filing reports the issuer has 59,914,473 shares outstanding. The document also lists multiple insider sales during the prior three months, including notable transactions by David Linetsky: 23,729 shares for $676,195.48 on 06/27/2025 and 17,445 shares for $518,681.81 on 08/22/2025. Other smaller sales by Jessica Weiss and additional sales by Linetsky are recorded with dates and gross proceeds. The filer certifies there is no undisclosed material adverse information known to the seller.
Form 144 filed for Phreesia, Inc. (PHR) reports a proposed sale of 3,761 common shares by a holder that acquired them on 09/11/2025 through restricted stock vesting and states the sale will be executed through Fidelity on the NYSE around 09/16/2025. The filing also discloses three prior sales by the same seller within the past three months: 1,892 shares on 07/17/2025 (gross proceeds $50,867.93), 45,147 shares on 08/27/2025 (gross proceeds $1,445,601.82) and 3,400 shares on 08/28/2025 (gross proceeds $110,369.37). The filer certifies no undisclosed material adverse information.
Phreesia, Inc. (PHR) filing of Form 144 reports a proposed sale of 4,183 common shares to be sold through Fidelity Brokerage Services on 09/16/2025 with an aggregate market value of $97,398.65. The shares were acquired on 09/11/2025 via restricted stock vesting and were paid as compensation. The filer, identified in prior sales as Balaji Gandhi, sold 886 shares on 07/17/2025 for $23,820.82 and 9,583 shares on 08/25/2025 for $287,550.07. The notice includes the standard representation that the seller does not possess undisclosed material adverse information about the issuer.
Amy Beth VanDuyn, SVP Human Resources and an officer and director of Phreesia, Inc. (PHR), received 3,634 restricted stock units (RSUs) that vested in full on September 11, 2025, representing her election to convert a cash bonus earned for the first half of the fiscal year ending January 31, 2026 into equity at a per-share value of $25.48. After the award, the reporting person beneficially owns 114,241 shares. The Form 4 was signed by power of attorney on September 15, 2025.
David Linetsky, President, Network Solutions at Phreesia, Inc. (PHR), reported grants of fully vested Restricted Stock Units on 09/11/2025. The filing shows the Reporting Person acquired 3,115 shares beneficially (RSUs converted in lieu of 50% of his cash bonus) and, indirectly through his spouse, 259 shares (RSUs converted in lieu of 50% of his spouse's cash bonus). The RSUs were calculated at $25.48 per share (the closing stock price on the grant date) and reflect an election to convert cash bonuses into RSUs at 115% of the earned amount. Following the reported transactions, the filing shows 177,117 shares beneficially owned directly and 9,976 shares indirectly. The Form 4 is signed by power of attorney on 09/15/2025.
Chaim Indig, Chief Executive Officer and Director of Phreesia, Inc. (PHR), reported a non-derivative acquisition on 09/11/2025. The report shows 10,696 restricted stock units (RSUs) were granted and treated as acquired, representing awards in lieu of the CEO's cash bonus for the first half of the fiscal year ending January 31, 2026. The Reporting Person elected to convert the cash bonus into RSUs at 115% of the earned amount, using a per-share value of $25.48 (the closing share price on 09/11/2025). After the transaction the filing reports 1,262,099 shares directly beneficially owned and 255,000 shares indirectly held through the Indig Dynasty Trust. The RSU shares (net of tax-withholding sales) must be held until the earlier of the one-year anniversary of grant or a Sale Event. The Form 4 was signed by power of attorney on 09/15/2025.
Evan Roberts, President, Provider Solutions at Phreesia, Inc. (PHR) reported a non-derivative acquisition on 09/11/2025 of 6,230 shares of common stock in the form of Restricted Stock Units (RSUs). The filing shows the RSUs vested on the grant date and were granted in lieu of a cash bonus earned for the first half of the fiscal year ending January 31, 2026 after the Reporting Person elected to convert the bonus into RSUs at 115% of the earned cash amount.
The grant used a per-share value of $25.48, the closing price on 09/11/2025. After the transaction the Reporting Person beneficially owned 730,598 shares. Shares underlying the RSUs (other than those sold non-discretionarily to cover taxes) must be held until the earlier of the one-year anniversary of the grant or a Sale Event as defined in the company plan. The Form 4 was signed on 09/15/2025 by Allison Hoffman by power of attorney for Evan Roberts.